Search

Dihydropyrimidine derivatives possess great potential to be used as a precursor for the synthesis of wide diverse dihydropyrimidine-like derivatives. In this research, the title compounds were synthesized through the reaction between 5-acetyl-4-(2,5-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-thione and 2,5-dimethoxybenzladehyde under aldol condensation condition. The title compound, (E)-3-(2,5-dimethoxyphenyl)-1-{[(4-(2,5-dimethoxyphenyl)-6-((E)-2,5-dimethoxystyryl)-2-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)]}prop-2-en-1-one (yield 15%), was obtained as major product, whereas (E)-3-(2,5-dimethoxyphenyl)-1-{[(4-(2,5-dimethoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydro pyrimidin-5-yl)]}prop-2-en-1-one (yield 8%) as side product through vinylogous aldol condensation.

A new compound belonging to a dihydrotetrazolopyrimidine derivative, that is, ethyl 5-methyl-7-(4-morpholinophenyl)-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate, was successfully synthesized using a Biginelli reaction between 4-morpholinobenzaldehyde, ethyl acetoacetate, and 5-aminotetrazole with p-toluenesulfonic acid (pTSA) as a catalyst in ethanol under reflux. The molecular structure of the title compound was characterized on the basis of spectroscopic evidence, using FTIR, HRESI-MS, 1H- and 13C-NMR, and 2D NMR.

A new compound belonging to the “heterostilbene” derivative, namely ethyl (E)-4-(2,4-dimethoxyphenyl)-6-(2,4-dimethoxystyryl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (2), has been successfully synthesized as an unprecedented side product of the Biginelli reaction between 2,4-dimethoxybenzaldehyde, ethyl acetoacetate and urea, employing PTSA as catalyst in reflux conditions and using ethanol as solvent. The molecular structure of compound (2) was established by FTIR, HRESIMS, 1D and 2D NMR.

The research about synthesis and characterization of chiral compounds from the rough methyleugenol with acetic acid as the catalyst has been done. The goal is to determine the content of 1-(3,4-dimetoksifenil)-2-propanil acetate compound which is produced in the reaction process of metileugenol with acetic acid and to characterizased the chemical compound of the product. The results showed that the content of 1-(3,4-dimetoksifenil)-2-propanil acetate compound that has been obtained was 45.87% with a molecular weight of 238.Keywords : Methyleugenol, Chiral, FT-IR, GC-MS

Infectious disease is one of sources of high morbidity and mortality caused by bacteria. Artocarpus plant is biosource to discover compounds with interesting bioactivites. The objective of this study is to find antibacterial compound from nature by extraction, fractionation, identification, and antibacterial test of secondary metabolite from dichloromethane extract of Artocarpus dasyphylla tree bark. The dichloromethane extract was fractionated repeatedly using various chromatographic techniques. The secondary metabolite was identified of its molecular structure based on UV-Vis, IR, NMR spectral data and confirmed by comparation with the reference. The secondary metabolite was known as catechin or 5,7,3’,4’-tetrahydroxyflavan-3β-ol. Antibacterial testing of cathecin against Escherechia coli and Staphylococcus aureus showed a low antibacterial activity.

A one-pot multicomponent reaction has been used to synthesize the title compound, ethyl 4-[5-(methoxymethyl)furan-2-yl]-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate by PTSA catalyzed Biginelli reaction. The chemical structure of the product was confirmed by spectroscopic evidence, FTIR, HRESI-MS, 1D-, and 2D NMR.